Evidence map›Paper›PMID 24063011›Full record

ArticleBioMed research international2013

The impact of Aspergillus fumigatus viability and sensitization to its allergens on the murine allergic asthma phenotype.

Sumali Pandey, Scott A Hoselton, Jane M Schuh

Abstract read
In one paragraph

Article in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Cytotoxicity ofToxins · 2022
    Article
  5. Review
  6. Factors Contributing to Sex Differences in Mice InhalingInternational journal of environmental research and public health · 2020
    Article
  7. Endothelin-1 mediates Aspergillus fumigatus-induced airway inflammation and remodelling.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2019
    Article
  8. Animal Models of Aspergillosis.Comparative medicine · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sumali PandeyDepartment of Veterinary and Microbiological Sciences, North Dakota State University, Fargo, ND 58108, USA.
Scott A Hoselton
Jane M Schuh

Funding

TARGETING AND DELIVERYP20RR015566 · NCRR · NORTH DAKOTA STATE UNIVERSITY · PI SINHA, SANGITA · 2001 to 2011
$19.0M
A novel model of fungal asthma using aeroallergen sensitization and challengeR15AI069061 · NIAID · NORTH DAKOTA STATE UNIVERSITY · PI SCHUH, JANE M. · 2006 to 2006
$214k
NCRR NIH HHS 2P20RR015566NCRR NIH HHS P20 RR015566NIAID NIH HHS 1R15AI69061NIAID NIH HHS R15 AI069061
6 · The paper itself

Abstract

Aspergillus fumigatus is a ubiquitously present respiratory pathogen. The outcome of a pulmonary disease may vary significantly with fungal viability and host immune status. Our objective in this study was (1) to assess the ability of inhaled irradiation-killed or live A. fumigatus spores to induce allergic pulmonary disease and (2) to assess the extent to which inhaled dead or live A. fumigatus spores influence pulmonary symptoms in a previously established allergic state. Our newly developed fungal delivery apparatus allowed us to recapitulate human exposure through repeated inhalation of dry fungal spores in an animal model. We found that live A. fumigatus spore inhalation led to a significantly increased humoral response, pulmonary inflammation, and airway remodeling in naïve mice and is more likely to induce allergic asthma symptoms than the dead spores. In contrast, in allergic mice, inhalation of dead and live conidia recruited neutrophils and induced goblet cell metaplasia. This data suggests that asthma symptoms might be exacerbated by the inhalation of live or dead spores in individuals with established allergy to fungal antigens, although the extent of symptoms was less with dead spores. These results are likely to be important while considering fungal exposure assessment methods and for making informed therapeutic decisions for mold-associated diseases.

Indexed as

ImmunizationAdministration, InhalationAirway RemodelingAllergensAnimalsAntibodies, FungalAntigens, FungalAspergillus fumigatusAsthmaGranulocytesHumansHypersensitivityImmunity, HumoralImmunity, MucosalMiceMice, Inbred BALB CAllergensAntibodies, FungalAntigens, Fungal

Identifiers

PMID24063011
PMCPMC3770015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.